CRISPR Therapeutics AG
(NASDAQ : CRSP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.01%90.691.3%$838.74m
AMGNAmgen Inc.
0.89%188.341.2%$621.82m
GILDGilead Sciences, Inc.
1.84%67.590.9%$512.40m
BIIBBiogen Inc.
2.51%332.871.3%$445.54m
REGNRegeneron Pharmaceuticals, Inc.
2.17%423.972.6%$305.14m
ILMNIllumina, Inc.
2.51%299.823.5%$302.67m
VRTXVertex Pharmaceuticals Incorporated
1.27%188.071.9%$269.75m
ALXNAlexion Pharmaceuticals, Inc.
2.77%129.422.0%$233.68m
LOXOLoxo Oncology Inc
-0.03%234.6612.7%$170.39m
SRPTSarepta Therapeutics, Inc.
2.65%138.4515.4%$148.57m
AAgilent Technologies, Inc.
1.64%78.281.6%$133.87m
INCYIncyte Corporation
0.88%84.152.5%$132.72m
EXASExact Sciences Corporation
0.49%88.5525.3%$128.36m
ARRYArray BioPharma Inc.
4.95%23.138.2%$105.79m
EXELExelixis, Inc.
-0.18%22.266.4%$97.74m

Company Profile

CRISPR Therapeutics AG engages in the development and commercializtion of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA. The company was founded by Rodger Novak, Emmanuelle Charpentier, and Shaun Patrick Foy in 2014 and is headquartered in Zug, Switzerland.